.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

GEODON Drug Profile

« Back to Dashboard
Geodon is a drug marketed by Pfizer and Pfizer Inc and is included in three NDAs. It is available from ten suppliers. There are six patents protecting this drug and one Paragraph IV challenge.

This drug has two hundred and thirty-six patent family members in fifty-four countries.

The generic ingredient in GEODON is ziprasidone hydrochloride. There are nineteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ziprasidone hydrochloride profile page.

Summary for Tradename: GEODON

Patents:6
Applicants:2
NDAs:3
Suppliers / Packagers: see list10

Pharmacology for Tradename: GEODON

Clinical Trials for: GEODON

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
GEODON
ziprasidone mesylate
INJECTABLE;INTRAMUSCULAR020919-001Jun 21, 2002RXYes6,232,304<disabled> <disabled>
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-002Feb 5, 2001RXNo6,150,366<disabled>Y <disabled>
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-001Feb 5, 2001RXYes6,245,766<disabled> <disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: GEODON

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
GEODON
ziprasidone mesylate
INJECTABLE;INTRAMUSCULAR020919-001Jun 21, 20025,134,127<disabled>
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-003Feb 5, 20015,312,925<disabled>
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-004Feb 5, 20015,312,925<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: GEODON

Drugname Dosage Strength RLD Submissiondate
ziprasidone hydrochlorideCapsules20 mg, 40 mg, 60 mg and 80 mgGeodon2/7/2005

International Patent Family for Tradename: GEODON

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)0072847<disabled in preview>
South Africa9703874<disabled in preview>
Guatemala199700042<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: GEODON

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2003004Lithuania<disabled>PRODUCT NAME: ZIPRASIDONUM (5-(2-(4-(1,2-BENZIZOTIAZOL-3-IL)-1-PIPERAZINIL)ETIL)-6-CHLOR-1,3-DIHIDRO-2H-INDOL-2-ONAS); REGISTRATION NO/DATE: 02/7887/8 20021002
2003004,C0904273Lithuania<disabled>PRODUCT NAME: ZIPRASIDONUM (5-(2-(4-(1,2-BENZIZOTIAZOL-3-IL)-1-PIPERAZINIL)ETIL)-6-CHLOR-1,3-DIHIDRO-2H-INDOL-2-ONAS); REGISTRATION NO/DATE: 02/7887/8 20021002
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc